Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07834398 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Weekly GLP-1 Receptor Agonists in Obese Individuals Without Diabetes

StatusCompleted
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Zagazig University
115 trials monitored
See 3 trials at risk
Diabetes
5,087 trials monitored
See 222 trials at risk
Obesity
3,874 trials monitored
See 152 trials at risk
This randomized controlled trial evaluates the efficacy of three weekly GLP-1 receptor agonists (dulaglutide, semaglutide, and tirzepatide) in non-diabetic obese adults. 150 participants with BMI \>30 will be randomized into three groups and followed for 6 months to assess changes in weight, BMI, lipid profile, and liver functions.
Trial Details
NCT Number NCT07834398
Lead Sponsor Zagazig University
Collaborators: Najran University
Conditions
(from sponsor)		 Non-diabetec Obesity, Obesity (Disorder)
Related terms Obesity
Enrollment 150 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov